(Q37788591)

23 August 2017

Idiopathic pulmonary fibrosis-an epidemiological and pathological review (English)

1 reference

23 August 2017

1 reference

1 reference

4

M Eric Gershwin

1 reference

23 August 2017

3

Carl L Keen

1 reference

23 August 2017

Andrea T Borchers

1

1 reference

PubMed ID

20838937

23 August 2017

Christopher Chang

series ordinal

2

1 reference

23 August 2017

1 April 2011

1 reference

Clinical Reviews in Allergy & Immunology

23 August 2017

1 reference

23 August 2017

40

1 reference

23 August 2017

2

1 reference

23 August 2017

117-134

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-010-8211-5

23 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis/usual interstitial pneumonia among Japanese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Early interstitial lung disease in familial pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Environmental, inhaled and ingested causes of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Familial idiopathic pulmonary fibrosis: clinical features and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Lung transplantation for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Incidence and prevalence of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Epidemiology of interstitial lung diseases in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Gene expression profiling of familial and sporadic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Adult familial cryptogenic fibrosing alveolitis in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Clinical and pathologic features of familial interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Telomerase mutations in families with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Adult-onset pulmonary fibrosis caused by mutations in telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Telomere shortening in familial and sporadic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Is idiopathic pulmonary fibrosis an environmental disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Determinants of initiation and progression of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Gastroesophageal reflux disease and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Viruses as co-factors for the initiation or exacerbation of lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Idiopathic pulmonary fibrosis and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Case-control study of medical history and idiopathic pulmonary fibrosis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Biology of fibroblasts and myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Bone marrow-derived progenitor cells in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Cell-specific gene expression in patients with usual interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Fibrotic myofibroblasts manifest genome-wide derangements of translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Hyperplastic epithelial foci in honeycomb lesions in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The perforin mediated apoptotic pathway in lung injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Platelet-derived growth factor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Usual interstitial pneumonitis is a T-cell alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Upregulation of tenascin and TGFbeta production in a type II alveolar epithelial cell line by antibody against a pulmonary auto-antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Anti-endothelial cell antibodies in patients with interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Dendritic cells accumulate in human fibrotic interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8211-5

Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society.

21 January 2018

1 reference

12 December 2020

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis

1 reference

12 December 2020

The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis

1 reference

12 December 2020

Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: quantitative immunohistochemistry

1 reference

12 December 2020

Structure of alveolar epithelial cells in patients with fibrotic lung disorders

1 reference

12 December 2020

Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis

1 reference

12 December 2020

Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF

1 reference

12 December 2020

The epidemiology of interstitial lung diseases

1 reference

12 December 2020

Interleukin-13 augments transforming growth factor-beta1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts

1 reference

12 December 2020

P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis

1 reference

12 December 2020

Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung

1 reference

12 December 2020

Report on the incidence of interstitial lung diseases in Spain

1 reference

12 December 2020

Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis

1 reference

12 December 2020

Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.

1 reference

12 December 2020

Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts

1 reference

12 December 2020

Usual interstitial pneumonia: histologic study of biopsy and explant specimens

1 reference

12 December 2020

Role of coagulation cascade proteases in lung repair and fibrosis.

1 reference

12 December 2020

The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

1 reference

12 December 2020

Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21

1 reference

12 December 2020

Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10

1 reference

12 December 2020

Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63.

1 reference

12 December 2020

Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases

1 reference

12 December 2020

Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study

1 reference

12 December 2020

Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis

1 reference

12 December 2020

The involvement of Fas-Fas ligand pathway in fibrosing lung diseases

1 reference

12 December 2020

Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis

1 reference

12 December 2020

Histopathologic variability in usual and nonspecific interstitial pneumonias

1 reference

12 December 2020

Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis

1 reference

12 December 2020

10.1007/S12016-010-8211-5

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20838937